Detalhe da pesquisa
1.
Zuranolone Concentrations in the Breast Milk of Healthy, Lactating Individuals: Results From a Phase 1 Open-Label Study.
J Clin Psychopharmacol
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739007
2.
A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adults.
Hum Psychopharmacol
; 37(1): e2806, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34352138
3.
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study.
Neuropsychopharmacology
; 49(2): 467-475, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875578
4.
Zuranolone for the Treatment of Postpartum Depression.
Am J Psychiatry
; 180(9): 668-675, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491938
5.
Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study.
J Neurol Sci
; 421: 117277, 2021 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387701
6.
SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies.
Clin Pharmacokinet
; 59(1): 111-120, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338688